RAWAT MOHIT (President and CBO) received a stock award from FUSION PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/5/2024ACC: 0000950170-24-002295
Officer· President and CBO
Since Sep 2021
+229.64K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
229.64K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+12.84K
Price / share
—
Trade value
—
% of position
New position
8/31/2023
0.00→12.84K
Total
Net shares
+12.84K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/31/2023 | A · Award | +12.84K | — | — | New position | 0.00 | 12.84K |
| Total | +12.84K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
135.50K shares
Shares
+135.50K
Strike price
8.44
Held after
135.50K
Exercisable
—
1/4/2024
Restricted Stock Units
Direct
Converts to
Common Stock
81.30K shares
Shares
+81.30K
Strike price
Held after
81.30K
Exercisable
—
1/4/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock135.50K shares | 1/4/2024 | A · Award | +135.50K | 8.44 | — | 135.50K |
| Restricted Stock Units Direct | Common Stock81.30K shares | 1/4/2024 | A · Award | +81.30K | — | 81.30K |